Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Intensity Allo-BMT with Photopheresis and Pentostatin for Relapsed Lymphoma
NCT00057954Phase 2Terminated
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Nov 2005
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pentostatin in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Eastern Cooperative Oncology Group. Started Nov 2005; status: terminated.
02
Drugs
pentostatin
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00057954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057954.